VCS, Virginia Cancer Specialis /ID# 169760 — Arlington, Virginia

VCS, Virginia Cancer Specialis /ID# 169760 is a clinical research site located in Arlington, Virginia, United States 22031.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

VCS, Virginia Cancer Specialis /ID# 169760 has participated in 1 clinical trials.

Therapeutic areas: Small Cell Lung Cancer.

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for VCS, Virginia Cancer Specialis /ID# 169760?

VCS, Virginia Cancer Specialis /ID# 169760 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has VCS, Virginia Cancer Specialis /ID# 169760 conducted?

VCS, Virginia Cancer Specialis /ID# 169760 has 1 clinical trials on record. Their work covers Small Cell Lung Cancer.

Is VCS, Virginia Cancer Specialis /ID# 169760 accredited by Crixeo Health?

VCS, Virginia Cancer Specialis /ID# 169760 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about VCS, Virginia Cancer Specialis /ID# 169760?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.